tandem diabetes care, inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. the company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. tandem manufactures and sells the t:slim x2™ insulin pump, the only pump capable of remote feature updates using a personal computer, and the t:flex® insulin pump, the first pump designed for people with greater insulin requirements. tandem is based in san diego, california. safety information please note that this account is not intended to be used for product support or medical advice. if you are having a medical emergency, please dial 911. if you are having an issue with one of our products and need immediate assistance, please call our 24 hour customer support team at 877-801-6901 and press 1 twice. tandem insulin pumps are intended for the subcutan
Company profile
Ticker
TNDM
Exchange
Website
CEO
John Sheridan
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Capillary Biomedical, LLC • Sugarmate, LLC • Tandem Diabetes Care Canada, Inc. • Tandem Diabetes Care Europe B.V. • Tandem Diabetes Care Switzerland Sarl ...
IRS number
204327508
TNDM stock data
Latest filings (excl ownership)
8-K
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
8 Mar 24
10-K
2023 FY
Annual report
21 Feb 24
8-K
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2023 Financial Results
21 Feb 24
8-K
Departure of Directors or Certain Officers
8 Dec 23
8-K
Departure of Directors or Certain Officers
9 Nov 23
8-K
Other Events
3 Nov 23
10-Q
2023 Q3
Quarterly report
1 Nov 23
8-K
Tandem Diabetes Care Announces Third Quarter 2023 Financial Results
1 Nov 23
8-K
Departure of Directors or Certain Officers
18 Aug 23
S-8
Registration of securities for employees
3 Aug 23
Transcripts
TNDM
Earnings call transcript
2023 Q4
21 Feb 24
TNDM
Earnings call transcript
2023 Q3
1 Nov 23
TNDM
Earnings call transcript
2023 Q2
3 Aug 23
TNDM
Earnings call transcript
2023 Q1
3 May 23
TNDM
Earnings call transcript
2022 Q4
22 Feb 23
TNDM
Earnings call transcript
2022 Q3
3 Nov 22
TNDM
Earnings call transcript
2022 Q2
4 Aug 22
TNDM
Earnings call transcript
2022 Q1
4 May 22
TNDM
Earnings call transcript
2021 Q4
23 Feb 22
TNDM
Earnings call transcript
2021 Q3
4 Nov 21
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 79.61 mm | 79.61 mm | 79.61 mm | 79.61 mm | 79.61 mm | 79.61 mm |
Cash burn (monthly) | 17.05 mm | 3.68 mm | 10.52 mm | 18.00 mm | (no burn) | 1.56 mm |
Cash used (since last report) | 101.99 mm | 22.02 mm | 62.91 mm | 107.66 mm | n/a | 9.36 mm |
Cash remaining | -22.37 mm | 57.59 mm | 16.70 mm | -28.05 mm | n/a | 70.25 mm |
Runway (months of cash) | -1.3 | 15.6 | 1.6 | -1.6 | n/a | 44.9 |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 232 |
Opened positions | 29 |
Closed positions | 47 |
Increased positions | 79 |
Reduced positions | 88 |
13F shares | Current |
---|---|
Total value | 1.44 tn |
Total shares | 78.11 mm |
Total puts | 289.20 k |
Total calls | 307.74 k |
Total put/call ratio | 0.9 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 8.86 mm | $183.95 bn |
Vanguard | 7.00 mm | $145.46 bn |
Capital World Investors | 6.55 mm | $135.95 bn |
Eminence Capital | 5.49 mm | $114.03 bn |
Corrib Capital Management | 4.50 mm | $13.14 mm |
FMR | 2.99 mm | $62.15 bn |
Alger Associates | 2.69 mm | $117.15 mm |
JHG Janus Henderson | 2.67 mm | $55.48 bn |
STT State Street | 2.17 mm | $45.07 bn |
BLVGF Bellevue | 2.14 mm | $44.51 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Mar 24 | Rick Carpenter | Common Stock | Payment of exercise | Dispose F | No | No | 28.62 | 145 | 4.15 k | 6,100 |
15 Mar 24 | Rick Carpenter | Common Stock | Option exercise | Acquire M | No | No | 0 | 405 | 0.00 | 6,245 |
15 Mar 24 | Rick Carpenter | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 405 | 0.00 | 2,842 |
27 Feb 24 | Morrison Susan | Common Stock | Payment of exercise | Dispose F | No | No | 27.34 | 113 | 3.09 k | 15,451 |
27 Feb 24 | Morrison Susan | Common Stock | Option exercise | Acquire M | No | No | 0 | 407 | 0.00 | 15,564 |
27 Feb 24 | Morrison Susan | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 407 | 0.00 | 406 |
27 Feb 24 | Sheridan John F | Common Stock | Payment of exercise | Dispose F | No | No | 27.34 | 293 | 8.01 k | 29,888 |
27 Feb 24 | Sheridan John F | Common Stock | Option exercise | Acquire M | No | No | 0 | 819 | 0.00 | 30,181 |
27 Feb 24 | Sheridan John F | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 819 | 0.00 | 820 |
27 Feb 24 | Vosseller Leigh | Common Stock | Payment of exercise | Dispose F | No | No | 27.34 | 142 | 3.88 k | 12,940 |
News
Stocks Inch Higher, Tesla Rebounds, Bitcoin Holds Below $70,000: What's Driving Markets Tuesday?
26 Mar 24
Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday
26 Mar 24
Stifel Upgrades Tandem Diabetes Care to Buy, Raises Price Target to $37
26 Mar 24
Stifel Upgrades Tandem Diabetes Care to Buy, Announces $37 Price Target
26 Mar 24
Citigroup Maintains Neutral on Tandem Diabetes Care, Raises Price Target to $31
15 Mar 24
Press releases
Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029
6 Mar 24
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
4 Mar 24
Tandem Diabetes Care Launches Tandem Mobi, the World's Smallest, Durable Automated Insulin Delivery System
13 Feb 24
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
22 Jan 24